Stephen Aronoff

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

Carel W. le Roux, Arne Astrup, Ken Fujioka et al. · The Lancet · 2017 · 813 citations

Obesity, Metabolic Syndrome, Nutrition +8

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

Roy W. Beck, Tonya D. Riddlesworth, Katrina J. Ruedy et al. · Annals of Internal Medicine · 2017 · 590 citations

Glucose Metabolism and Regulation: Beyond Insulin and Glucagon

Stephen Aronoff, Kathy J. Berkowitz, Barb Shreiner et al. · Diabetes Spectrum · 2004 · 566 citations

Metabolic Syndrome, Insulin Signaling, Diabetes Management +14

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet · 2011 · 484 citations

Type 1, Disease Management, Diabetes Management +7

The prevalence of anemia in patients with chronic kidney disease

William McClellan, Stephen Aronoff, W. Kline Bolton et al. · Current Medical Research and Opinion · 2004 · 468 citations